Work

EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

Year: 2025

Type: other

Abstract: EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool, called AIM-NASH, helps pathologists analyse liver biopsy scans to identify the severity of MASH (metabolic dysfunction associated steatohepatitis; formerly known as non-alcoholic steatohepatitis NASH) in clinical trials. MASH is a condition where fat builds up in the liver, causing inflammation, irritation and scarrin...

Source: Industrias Culturais (Universidade de Coimbra)

DOI: 10.58079/13xy8

Author: Vroby

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6974032763

Cites:

Cited by:

Related to: